Heron Bay Capital Management Abb Vie Inc. Transaction History

Heron Bay Capital Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$131.98 - $163.75 $1.98 Million - $2.46 Million	-15,018 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$107.43 - $135.93 $31,369 - $39,691	292 Added 1.98%	15,018 $2.03 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $244,613 - $277,673	2,299 Added 18.5%	14,726 $1.59 Million
Q2 2021 Aug 10, 2021	SELL	$105.21 - $117.21 $42,610 - $47,470	-405 Reduced 3.16%	12,427 $1.4 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $261,069 - $287,406	2,552 Added 24.82%	12,832 $1.39 Million

Q4 2020 Feb 16, 2021	BUY	$80.49 - $108.67 $827,437 - $1.12 Million	10,280 New	10,280 $1.1 Million

3,651

1.24B

15.5M

11.6M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $303B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Heron Bay Capital Management, based on Form 13F filings with the SEC.

Stay updated on Heron Bay Capital Management with notifications on news.